• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乙酰化代谢表型及利福平初始口服/静脉给药在结核病治疗中的意义]

[Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].

作者信息

Loos U, Musch E, Schwabe H K

机构信息

Medizinische Universitätsklinik Bonn.

出版信息

Pneumologie. 1990 Feb;44 Suppl 1:488-9.

PMID:2367445
Abstract

In a pilot study involving 62 patients with open pulmonary tuberculosis, we established that slow acetyators and patients receiving intravenous rifampicin treatment showed a tendency towards a more rapid negativisation of the sputum culture than did fast acetyators (lower levels of isoniazid) or patients receiving oral rifampicin therapy (decreasing bioavailability of the rifampicin during treatment).

摘要

在一项针对62例开放性肺结核患者的初步研究中,我们发现,慢乙酰化者以及接受静脉注射利福平治疗的患者,与快乙酰化者(异烟肼水平较低)或接受口服利福平治疗的患者(治疗期间利福平的生物利用度降低)相比,痰培养转阴的速度有更快的趋势。

相似文献

1
[Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].[乙酰化代谢表型及利福平初始口服/静脉给药在结核病治疗中的意义]
Pneumologie. 1990 Feb;44 Suppl 1:488-9.
2
Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol.利福平、异烟肼和乙胺丁醇复方片剂与含利福平胶囊和含异烟肼及乙胺丁醇片剂联合给药的相对生物利用度。
Arzneimittelforschung. 1995 Nov;45(11):1236-9.
3
[Tisamide in the complex treatment of tuberculosis].[替沙米特在结核病综合治疗中的应用]
Probl Tuberk. 1990(7):43-5.
4
[Intravenous rifampicin therapy in open tuberculosis].[开放性肺结核的静脉注射利福平治疗]
Med Welt. 1983 Jun 17;34(24):701-3.
5
Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months.肺结核简化短程治疗:乙胺丁醇、利福平及异烟肼治疗2个月,随后异烟肼或利福平治疗4个月的方案经验
Bull Int Union Tuberc. 1976;51(1):87-9.
6
A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.口服短程疗法治疗痰菌阳性肺结核的对照临床试验。结核病研究中心。
Int J Tuberc Lung Dis. 1997 Dec;1(6):509-17.
7
[Clinico-pharmacological approach to rifampicin and isoniazid dosage].[利福平与异烟肼剂量的临床药理学方法]
Probl Tuberk. 1987(9):31-4.
8
Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.对既往未接受治疗的肺结核患者,采用利福平-异烟肼联合用药进行为期6个月的对照治疗试验。
Bull Int Union Tuberc. 1972 Feb;47:37-40.
9
Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.利福平、乙胺丁醇和异烟肼治疗结核病:1972 - 1974年丹麦结核病试验
Eur J Respir Dis. 1982 Mar;63(2):84-93.
10
[Long term results of short course chemotherapy in pulmonary tuberculosis--(1st study):twelve- and eighteen-month chemotherapy with rifampicin-isoniazid and ethambutol].
Kekkaku. 1986 Jul;61(7):371-7.